药品保健品
Search documents
十个综合整治“内卷式”竞争重大案件发布!这场发布会带你一览
Bei Jing Ri Bao Ke Hu Duan· 2026-01-27 08:05
Core Viewpoint - The State Administration for Market Regulation (SAMR) is intensifying efforts to combat "involution" in competition by announcing ten major cases that highlight its commitment to maintaining fair market order and addressing various forms of unfair competition [2][4]. Group 1: Overview of Major Cases - The ten major cases cover a wide range of sectors, from traditional manufacturing to platform economies, and involve various stages from product manufacturing to certification services [4]. - The cases aim to demonstrate the effectiveness of enforcement actions and to guide industries towards healthy and sustainable development [4]. Group 2: Specific Cases - Case 1: "Putian Comes" chain enterprise was penalized for infringing trademark rights, dismantling a large-scale counterfeit network to curb low-price malicious competition [5]. - Case 2: Shenzhen Romoss Technology Co., Ltd. was fined for violating mandatory product certification regulations and false advertising, sending a clear regulatory signal for industry health [5]. - Case 3: A monopoly agreement involving four companies in the sodium dexamethasone raw material market resulted in a total fine of 362 million yuan, enhancing antitrust enforcement [5]. - Case 4: The merger between China Petroleum Group and CATL was approved to promote innovation and escape homogeneous competition [5]. - Case 5: Shanxi Laoge Trading Co., Ltd. faced penalties for false advertising and price fraud through live streaming, with fines totaling 5.6 million yuan [5]. Group 3: Regulatory Focus and Future Actions - The SAMR emphasizes a "zero tolerance" approach towards infringement, quality violations, and monopoly agreements, showcasing strong regulatory constraints [7]. - Future actions will focus on maintaining high-pressure enforcement, improving long-term regulatory mechanisms, and promoting a market order characterized by quality and fair pricing [7][29]. - The SAMR will continue to address the complexities of "involution" in various industries, aiming for targeted governance and effective law enforcement [7].
药品保健品坑老专项整治启动!南都曾起底“诱导式剧本”乱象
Nan Fang Du Shi Bao· 2025-05-28 06:39
Group 1 - The State Administration for Market Regulation has initiated a nationwide campaign to address false advertising in the pharmaceutical and health product sectors targeting the elderly, aiming to combat fraudulent practices that exploit this demographic [1][2] - Local market regulation departments will focus on illegal activities such as false advertising, price fraud, and illegal additives that infringe on the rights of the elderly and disrupt market competition [2] - The campaign includes a "You Shoot, We Check" initiative, encouraging the public to report suspected illegal activities, thereby enhancing the protection of elderly consumers and improving the market environment [2] Group 2 - Investigations have revealed that some live-streaming influencers engage in deceptive practices, using dramatic scripts to attract viewers and promote products that do not have legitimate health benefits [2][3] - Concerns have been raised about the sale of counterfeit health products and medications through live streams, which could lead to health risks for elderly consumers [3] - Legal experts have indicated that selling unregulated or counterfeit products during live streams could result in severe legal consequences, including charges related to fraud and violations of consumer protection laws [3]